165 related articles for article (PubMed ID: 36540526)
1. A Rare Nephrotic Syndrome Related to Chronic Lymphocytic Leukemia: Focal Segmental Glomerulosclerosis.
Karakus V; Atas U; Uzuntas S; Dere Y; Meteoglu I
Cureus; 2022 Nov; 14(11):e31545. PubMed ID: 36540526
[TBL] [Abstract][Full Text] [Related]
2. Concurrent FSGS and Hodgkin's lymphoma: case report and literature review on the link between nephrotic glomerulopathies and hematological malignancies.
Mallouk A; Pham PT; Pham PC
Clin Exp Nephrol; 2006 Dec; 10(4):284-9. PubMed ID: 17186334
[TBL] [Abstract][Full Text] [Related]
3. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous clinical resolution of focal segmental glomerulosclerosis associated with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab.
Arampatzis S; Giannakoulas N; Liakopoulos V; Eleftheriadis T; Kourti P; Karasavvidou F; Matsouka P; Stefanidis I
BMC Nephrol; 2011 Jul; 12():33. PubMed ID: 21729272
[TBL] [Abstract][Full Text] [Related]
5. Variant Richter's syndrome: a rare case of classical Hodgkin's lymphoma developing in a patient with chronic lymphocytic leukemia treated with fludarabine.
Nemets A; Ben Dor D; Barry T; Ducach A; Blumental R; Ben Alon D; Lugassy G
Leuk Lymphoma; 2003 Dec; 44(12):2151-4. PubMed ID: 14959863
[TBL] [Abstract][Full Text] [Related]
6. Membranoproliferative glomerulonephritis and light-chain nephropathy in association with chronic lymphocytic leukemia.
Mutluay R; Aki SZ; Erten Y; Konca C; Yagci M; Barit G; Sindel S
Clin Nephrol; 2008 Dec; 70(6):527-31. PubMed ID: 19049712
[TBL] [Abstract][Full Text] [Related]
7. Rituximab for Adults With Multi-Drug Resistant Focal Segmental Glomerulosclerosis: A Case Series and Review of the Literature.
Zhong E; Ghadiri S; Pai A; Marin JG; Barbour SJ
Can J Kidney Health Dis; 2022; 9():20543581221090010. PubMed ID: 35465258
[TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness and cost-effectiveness results from the randomised, Phase IIB trial in previously untreated patients with chronic lymphocytic leukaemia to compare fludarabine, cyclophosphamide and rituximab with fludarabine, cyclophosphamide, mitoxantrone and low-dose rituximab: the Attenuated dose Rituximab with ChemoTherapy In Chronic lymphocytic leukaemia (ARCTIC) trial.
Howard DR; Munir T; McParland L; Rawstron AC; Chalmers A; Gregory WM; O'Dwyer JL; Smith A; Longo R; Varghese A; Smith A; Hillmen P
Health Technol Assess; 2017 May; 21(28):1-374. PubMed ID: 28628003
[TBL] [Abstract][Full Text] [Related]
9. [Minimal-change glomerulonephritis in chronic lymphocytic leukemia: A clinical case].
Dzhumabaeva BT; Biryukova LS; Golitsyna EP; Varshavsky VA
Ter Arkh; 2015; 87(12):85-88. PubMed ID: 26978424
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune cytopenia does not predict poor prognosis in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Kyasa MJ; Parrish RS; Schichman SA; Zent CS
Am J Hematol; 2003 Sep; 74(1):1-8. PubMed ID: 12949883
[TBL] [Abstract][Full Text] [Related]
11. Fludarabine, cyclophosphamide, and multiple-dose rituximab as frontline therapy for chronic lymphocytic leukemia.
Short NJ; Keating MJ; Wierda WG; Faderl S; Ferrajoli A; Estrov Z; Smith SC; O'Brien SM
Cancer; 2015 Nov; 121(21):3869-76. PubMed ID: 26218678
[TBL] [Abstract][Full Text] [Related]
12. Low-dose fludarabine and cyclophosphamide combined with standard dose rituximab (LD-FCR) is an effective and safe regimen for elderly untreated patients with chronic lymphocytic leukemia: The Israeli CLL study group experience.
Herishanu Y; Tadmor T; Braester A; Bairey O; Aviv A; Rahimi-Levene N; Fineman R; Levi I; Yuklea M; Ruchlemer R; Shvidel L; Polliack A
Hematol Oncol; 2019 Apr; 37(2):185-192. PubMed ID: 30756414
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune cytopenias in chronic lymphocytic leukemia, facts and myths.
Tandra P; Krishnamurthy J; Bhatt VR; Newman K; Armitage JO; Akhtari M
Mediterr J Hematol Infect Dis; 2013 Nov; 5(1):e2013068. PubMed ID: 24363883
[TBL] [Abstract][Full Text] [Related]
14. Case Report: Chronic Lymphocytic Leukemia With Recurrent Complement-Mediated Thrombotic Microangiopathy and C3 Glomerulonephritis.
Ma T; Wang H; Su T; Wang S
Front Med (Lausanne); 2022; 9():813439. PubMed ID: 35223908
[TBL] [Abstract][Full Text] [Related]
15. Unusual Relapse of Chronic Lymphocytic Leukemia After Remission.
Rizvi W; Truong Q
Cureus; 2018 Feb; 10(2):e2176. PubMed ID: 29651369
[TBL] [Abstract][Full Text] [Related]
16. Case Report: Rapid renal response to venetoclax monotherapy in a CLL patient with secondary membranous glomerulonephritis.
Lovato E; Gangemi C; Krampera M; Visco C; Ferrarini I
Front Oncol; 2023; 13():1108994. PubMed ID: 37152058
[TBL] [Abstract][Full Text] [Related]
17. [Chronic lymphocytic leukemia].
Maurer C; Hallek M
Dtsch Med Wochenschr; 2013 Oct; 138(42):2153-66. PubMed ID: 24104591
[TBL] [Abstract][Full Text] [Related]
18. Demyelinating brain lesions developing in a patient with chronic lymphocytic leukemia shortly after treatment with a fludarabine containing regimen.
Kreiniz N; Garty-Ofir M; Bejar J; Polliack A; Tadmor T
Hematol Oncol; 2021 Feb; 39(1):129-133. PubMed ID: 33038272
[TBL] [Abstract][Full Text] [Related]
19. Nephrotic syndrome with focal segmental glomerulosclerosis after an insect bite.
Révai T; Kaszás I; Márton C; Arpási G; Winkler G
Clin Nephrol; 2006 Aug; 66(2):128-30. PubMed ID: 16939069
[TBL] [Abstract][Full Text] [Related]
20. Rituximab therapy for chronic lymphocytic leukemia-associated autoimmune hemolytic anemia.
D'Arena G; Laurenti L; Capalbo S; D'Arco AM; De Filippi R; Marcacci G; Di Renzo N; Storti S; Califano C; Vigliotti ML; Tarnani M; Ferrara F; Pinto A
Am J Hematol; 2006 Aug; 81(8):598-602. PubMed ID: 16823816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
